Country focus healthcare, regulatory and reimbursement landscape us - Reports Corner

  • 175 views
Uploaded on

GlobalData, the industry analysis specialist, has released its new report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - US”. The report is an essential source of information and …

GlobalData, the industry analysis specialist, has released its new report, “CountryFocus: Healthcare, Regulatory and Reimbursement Landscape - US”. The report is an essential source of information and analysis on the healthcare, regulatory and reimbursement landscape of US.

https://www.reportscorner.com/reports/21521/CountryFocus:-Healthcare,-Regulatory-and-Reimbursement-Landscape---US/

  • Full Name Full Name Comment goes here.
    Are you sure you want to
    Your message goes here
    Be the first to comment
    Be the first to like this
No Downloads

Views

Total Views
175
On Slideshare
0
From Embeds
0
Number of Embeds
0

Actions

Shares
Downloads
0
Comments
0
Likes
0

Embeds 0

No embeds

Report content

Flagged as inappropriate Flag as inappropriate
Flag as inappropriate

Select your reason for flagging this presentation as inappropriate.

Cancel
    No notes for slide

Transcript

  • 1. RCReports CornerCountryFocus: Healthcare, Regulatory andReimbursement Landscape - US
  • 2. DescriptionDescriptionReports Cornerwww.reportscorner.comGlobalData, the industry analysis specialist, has released its newreport, “CountryFocus: Healthcare, Regulatory andReimbursement Landscape - US”. The report is an essentialsource of information and analysis on the healthcare, regulatoryand reimbursement landscape of US.
  • 3. Brief SummaryBrief SummaryReports Cornerwww.reportscorner.comCountryFocus: Healthcare, Regulatory and ReimbursementLandscape - USSummaryGlobalData, the industry analysis specialist, has released its newreport, “CountryFocus: Healthcare, Regulatory andReimbursement Landscape - US”. The report is an essentialsource of information and analysis on the healthcare, regulatoryand reimbursement landscape of US. The report identifies the keytrends in the healthcare market of US. The report also providesinsights on the demographic, regulatory, reimbursementlandscape and healthcare infrastructure of US. Most importantly,the report provides valuable insights on the trends andsegmentation of the pharmaceutical and medical devices market.
  • 4. Brief SummaryBrief SummaryReports Cornerwww.reportscorner.comThis report is built using data and information sourced fromproprietary databases, secondary research and in-house analysisby GlobalDatas team of industry experts.In 2012, US was the third most populated country in the worldwith a population of approximately 316.2 million. The populationof US is increasing at a slow rate of growth due to a negativebalance between the mortality and birth rate and low fertility rate.The decline in the population of the working age group and theincreasing elderly population are matters of concern for US policyplanners. The pharmaceutical market in US was estimated atapproximately $359 billion in 2012 and is expected to reachapproximately $475 billion by 2020, with a projected CAGR of3.5%. The medical device market size was approximately $138.9billion in 2012 and is expected to reach approximately $206 billionby 2020, at a projected CAGR of 5.1%.
  • 5. Brief SummaryBrief SummaryReports Cornerwww.reportscorner.comScopeThe report provides information on the healthcare, regulatory andreimbursement landscape of US. The scope of the report includes-- An overview of the pharmaceutical and medical devices marketof US including the market size, market segmentation, key driversand barriers for the market.- Profiles and SWOT analyses of the major players in thepharmaceutical and medical devices market. Key players coveredin the pharmaceutical market are Pfizer, Merck & Co., Roche,Abbott and Novartis. Key players covered for the medical devicesmarket are Medtronic, Boston Scientific, Abbott, GlaxoSmithKlineand Siemens Healthcare.
  • 6. Brief SummaryBrief SummaryReports Cornerwww.reportscorner.com- An insightful review on the reimbursement and regulatorylandscape. Analysis includes details of the healthcarereimbursement process, regulatory agencies and marketauthorization processes for new drug and medical devices for US.- A detailed analysis of the political and economic environment ofUS, including economic indicators, demographics, healthcareinfrastructure and healthcare expenditure.- An overview of the opportunities and challenges for growth thatexist in the healthcare market of US.Reasons to buyThe report on US comprehensively covers both thepharmaceutical and medical devices markets of US. The reportwill enhance your decision-making capability. It will allow you to -- Develop business strategies by understanding the trendsshaping and driving the healthcare market of US.
  • 7. Brief SummaryBrief SummaryReports Cornerwww.reportscorner.com- Drive revenues by understanding the key trends, reimbursementand regulatory policies, pharmaceutical and medical devicesmarket segments and companies likely to impact US healthcaremarket in the future.- Formulate effective sales and marketing strategies byunderstanding the competitive landscape and by analyzing theperformance of various competitors.- Organize your sales and marketing efforts by identifying themarket categories and segments that present the greatestopportunities for consolidations, investments and strategicpartnerships.- Identify, understand and capitalize on the opportunities andchallenges in the healthcare market of US.
  • 8. Table of ContentsTable of ContentsReports Cornerwww.reportscorner.com1 Table of Contents1 Table of Contents 61.1 List of Tables 101.2 List of Figures 142 Introduction 192.1 Report Guidance 193 Overview of the Pharmaceutical and Medical Device Markets 203.1 Pharmaceutical Market 203.1.1 Market Overview 203.1.2 Supply Channels 273.1.3 Market Segments 303.1.4 Overview of Major Disease Segments 463.1.5 Major Players 503.2 Medical Device Market 1053.2.1 Market Overview 105
  • 9. Table of ContentsTable of ContentsReports Cornerwww.reportscorner.com3.2.2 Overview of Top Five Segments 1073.2.3 Diagnostic Market 1183.2.4 Major Players 1203.3 Market Drivers and Barriers 1583.3.1 Drivers 1583.3.2 Barriers 1604 Market Access 1654.1.1 Reimbursement and Payer Landscape 1654.1.2 Health Insurance and Managed Care in US 1664.1.3 Overview of Insurance Providers 1714.1.4 Patient Share in Healthcare Spending 1844.1.5 Prescription Drug Price Trend 1864.1.6 Pricing Policies 1874.2 Regulatory Landscape 1904.2.1 Overview of Regulatory Agencies 190
  • 10. Table of ContentsTable of ContentsReports Cornerwww.reportscorner.com4.2.2 New Drug Approval Process 1914.2.3 Approval Process of Biological Products as Biosimilar or Interchangeable 2084.2.4 New Medical Device Approval Process 2094.2.5 Licensing Process for Pharmaceutical and Medical Device Manufacturing 2174.2.6 Licensing Process for Pharmaceutical Exports and Imports 2224.2.7 Intellectual Property Rights 2364.2.8 Clinical Trial Regulations 2394.2.9 Pharmaceutical Advertising Regulations 2444.2.10 Pharmacy Regulations 2454.2.11 Labeling and Packaging Regulations 2475 Country Analysis 2505.1 Political Environment 2505.1.1 Political Structure 2505.1.2 Analysis of Current Political Environment 2515.1.3 Healthcare Policy Initiatives 254
  • 11. Table of ContentsTable of ContentsReports Cornerwww.reportscorner.com5.2 Economic Landscape 2595.3 Economic Indicators 2655.3.1 Gross Domestic Product 2655.3.2 Gross National Income 2695.3.3 Inflation 2705.3.4 Currency Exchange Rate 2735.3.5 Foreign Direct Investment 2765.3.6 Foreign Exchange Reserves 2775.3.7 Trade Balance 2785.3.8 Government Structural Balance 2815.3.9 Government Net Debt 2835.3.10 Major Industries 2855.4 Demography 2865.4.1 Population 2865.4.2 Education and Literacy 303
  • 12. Table of ContentsTable of ContentsReports Cornerwww.reportscorner.com5.4.3 Employment 3055.4.4 Disease Burden 3075.5 Healthcare Infrastructure 3105.5.1 Healthcare Facilities 3105.5.2 Healthcare Parameters 3185.5.3 Environmental Health 3225.5.4 Healthcare Personnel 3275.6 Healthcare Expenditure 3285.6.1 Overview 3285.6.2 Major Components of Healthcare Spending 3295.6.3 Share of Public and Private Sectors 3315.6.4 Spending in Pharmaceutical R&D 3325.7 Trade Associations 3345.7.1 Pharmaceutical Research and Manufacturers of America 3345.7.2 Consumer Healthcare Products Association 334
  • 13. Table of ContentsTable of ContentsReports Cornerwww.reportscorner.com5.7.3 International Pharmaceutical Excipients Council 3345.7.4 Advanced Medical Technology Association 3355.7.5 National Association for Home Care & Hospices 3355.7.6 Biotech Industry Association 3355.7.7 The Society of Chemical Manufacturers and Affiliates 3365.8 Trade Fairs 3366 Opportunities and Challenges 3396.1 Opportunities 3396.2 Challenges 3417 Appendix 3447.1 Abbreviations 3447.2 Bibliography 3537.3 Methodology 3697.3.1 Coverage 3697.3.2 Secondary Research 369
  • 14. Table of ContentsTable of ContentsReports Cornerwww.reportscorner.com7.3.3 Forecasting 3707.3.4 Expert Panel Validation 3707.4 Contact Us 3707.5 Disclaimer 371
  • 15. For more informationFor more informationReports Cornerwww.reportscorner.comFor more information please visit our websitehttps://www.reportscorner.com/reports/21521/CountryFocus:-Healthcare,-Regulatory-and-Reimbursement-Landscape---US/
  • 16. Reports CornerThank YouThank Youwww.reportscorner.comRCContact us: contact@reportscorner.com